198 related articles for article (PubMed ID: 6290115)
1. Effects of muramyl dipeptide on superoxide anion release and on anti-microbial activity of human macrophages.
Wilson CB; Bohnsack J; Weaver WM
Clin Exp Immunol; 1982 Aug; 49(2):371-6. PubMed ID: 6290115
[TBL] [Abstract][Full Text] [Related]
2. Oxidative metabolic response and microbicidal activity of human milk macrophages: effect of lipopolysaccharide and muramyl dipeptide.
Cummings NP; Neifert MR; Pabst MJ; Johnston RB
Infect Immun; 1985 Aug; 49(2):435-9. PubMed ID: 2991139
[TBL] [Abstract][Full Text] [Related]
3. Biphasic effects of muramyl dipeptide or lipopolysaccharide on superoxide anion-generating activities of macrophages.
Yagawa K; Kaku M; Ichinose Y; Nagao S; Tanaka A; Tomoda A
Infect Immun; 1984 Jul; 45(1):82-6. PubMed ID: 6329960
[TBL] [Abstract][Full Text] [Related]
4. Lipophilic derivative of muramyl dipeptide is more active than muramyl dipeptide in priming macrophages to release superoxide anion.
Pabst MJ; Cummings NP; Shiba T; Kusumoto S; Kotani S
Infect Immun; 1980 Aug; 29(2):617-22. PubMed ID: 6260655
[TBL] [Abstract][Full Text] [Related]
5. Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide.
Cummings NP; Pabst MJ; Johnston RB
J Exp Med; 1980 Dec; 152(6):1659-69. PubMed ID: 6256464
[TBL] [Abstract][Full Text] [Related]
6. Chronic infection due to Mycobacterium intracellulare in mice: association with macrophage release of prostaglandin E2 and reversal by injection of indomethacin, muramyl dipeptide, or interferon-gamma.
Edwards CK; Hedegaard HB; Zlotnik A; Gangadharam PR; Johnston RB; Pabst MJ
J Immunol; 1986 Mar; 136(5):1820-7. PubMed ID: 3005400
[TBL] [Abstract][Full Text] [Related]
7. Release of superoxide anion and enhanced candidacidal activity as a manifestation of macrophage activation: studies with muramyl dipeptide.
Cummings NP; Pabst MJ; Johnston RB
Adv Exp Med Biol; 1982; 141():179-87. PubMed ID: 6283823
[No Abstract] [Full Text] [Related]
8. Modulation of pulmonary macrophage superoxide release and tumoricidal activity following activation by biological response modifiers.
Drath DB
Immunopharmacology; 1986 Oct; 12(2):117-26. PubMed ID: 3021650
[TBL] [Abstract][Full Text] [Related]
9. Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide.
Pabst MJ; Johnston RB
J Exp Med; 1980 Jan; 151(1):101-14. PubMed ID: 7350246
[TBL] [Abstract][Full Text] [Related]
10. Enhanced superoxide anion release from phagocytes by muramyl dipeptide or lipopolysaccharide.
Kaku M; Yagawa K; Nagao S; Tanaka A
Infect Immun; 1983 Feb; 39(2):559-64. PubMed ID: 6299943
[TBL] [Abstract][Full Text] [Related]
11. [Antitumoral activation of rat peritoneal macrophages by muramyl dipeptide in vitro].
Reisser D; Jeannin JF; Martin F
C R Seances Acad Sci III; 1982 Nov; 295(8):485-8. PubMed ID: 6819063
[TBL] [Abstract][Full Text] [Related]
12. Muramyl dipeptide enhances in vitro peritoneal macrophage phagocytic activity.
McCoy DM; Brown GL; Ausobsky JR; Polk HC
Am Surg; 1985 Nov; 51(11):634-6. PubMed ID: 4062058
[TBL] [Abstract][Full Text] [Related]
13. Muramyl peptides and serotonin interact at specific binding sites on macrophages and enhance superoxide release.
Silverman DH; Wu H; Karnovsky ML
Biochem Biophys Res Commun; 1985 Sep; 131(3):1160-7. PubMed ID: 2996538
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent effects of aminobutyryl muramyl dipeptide on alveolar macrophage function in infant and adult Macaca monkeys.
Jacobs RF; Wilson CB; Smith AL; Haas JE
Am Rev Respir Dis; 1983 Nov; 128(5):862-7. PubMed ID: 6638675
[TBL] [Abstract][Full Text] [Related]
15. The activation of human monocytes by liposome-encapsulated muramyl dipeptide analogues.
Lopez-Berestein G; Mehta K; Mehta R; Juliano RL; Hersh EM
J Immunol; 1983 Apr; 130(4):1500-2. PubMed ID: 6300230
[No Abstract] [Full Text] [Related]
16. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
Phillips NC; Chedid L; Bernard JM; Level M; Lefrancier P
J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784
[TBL] [Abstract][Full Text] [Related]
17. Human macrophages may normally be "primed" for a strong oxygen radical response.
Pabst MJ; Cummings NP; Hedegaard HB; Johnston RB
Adv Exp Med Biol; 1983; 166():215-21. PubMed ID: 6316765
[TBL] [Abstract][Full Text] [Related]
18. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.
Sone S; Tachibana K; Shono M; Ogushi F; Tsubura E
J Biol Response Mod; 1984; 3(2):185-94. PubMed ID: 6726281
[TBL] [Abstract][Full Text] [Related]
19. Oxidative metabolism in cord blood monocytes and monocyte-derived macrophages.
Speer CP; Ambruso DR; Grimsley J; Johnston RB
Infect Immun; 1985 Dec; 50(3):919-21. PubMed ID: 2999001
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulation of macrophages by muramyl peptides: recent findings concerning somnogenic activity of muramyl peptides and monokine.
Leclerc C; Chedid L
Int J Tissue React; 1984; 6(3):215-8. PubMed ID: 6332794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
